Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11523501 | 0.84 | HDAC4 (0.35) | CTSKHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL29216098 | 0.81 | TDP1 (0.39) | CTSKNPSR1TBXAS1KMT2AMEN1 | |
| SCHEMBL29216002 | 0.76 | TDP1 (0.40) | TBXAS1KMT2AMEN1MAPK1 | |
| SCHEMBL2919621 | 0.75 | HDAC4 (0.39) | CTSKHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL10171591 | 0.73 | HDAC4 (0.38) | CTSKHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL28941422 | 0.72 | CTSK (0.33) | CTSK | |
| SCHEMBL988375 | 0.72 | PTGS1 (0.39) | HDAC4HDAC2HDAC8HDAC6KMT2A | |
| SCHEMBL8045674 | 0.72 | HDAC4 (0.37) | CTSKHDAC4HDAC2HDAC8HDAC6 | |
| SCHEMBL3503463 | 0.72 | HDAC4 (0.37) | HDAC4HDAC2HDAC8HDAC6NPSR1 | |
| SCHEMBL10435436 | 0.71 | TBXAS1 (0.38) | CTSKHDAC4HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023232948-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2023-12-07 | — | — | WO | disclosed |
| EP-4286369-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2023-12-06 | — | — | EP | disclosed |
| CN-104262197-A | Synthesis method of 1-cyclohexenylacetonitrile | TAICANG YUNTONG BIOCHEMICAL ENGINEERING CO LTD | 2015-01-07 | — | — | CN | disclosed |
| EP-0388587-B1 | PROCESS FOR THE INDUSTRIAL KNOEVENAGEL SYNTHESIS | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-11-11 | — | — | EP | disclosed |
| US-5008429-A | Controlling the flow of waste gas using acetic acid | HUELS AKTIENGESELLSCHAFT (DE) | 1991-04-16 | — | — | US | disclosed |
| EP-0388587-A1 | Process for the industrial Knoevenagel synthesis | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-09-26 | — | — | EP | disclosed |
| US-4731391-A | Process of making a superabsorbent polyurethane foam | KIMBERLY-CLARK CORPORATION (US) | 1988-03-15 | — | — | US | disclosed |
| US-4725629-A | Process of making an interpenetrating superabsorbent polyurethane foam | KIMBERLY-CLARK CORPORATION (US) | 1988-02-16 | — | — | US | disclosed |
| US-4725628-A | Process of making a crosslinked superabsorbent polyurethane foam | KIMBERLY-CLARK CORPORATION (US) | 1988-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | CTSK 3688/4885HDAC4 4116/4885HDAC2 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.